These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26560730)

  • 1. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.
    Ferreira D; Cavallin L; Granberg T; Lindberg O; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    Eur Radiol; 2016 Aug; 26(8):2597-610. PubMed ID: 26560730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.
    Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L
    Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Efficient Combination among sMRI, CSF, Cognitive Score, and
    Khatri U; Kwon GR
    Comput Intell Neurosci; 2020; 2020():8015156. PubMed ID: 32565773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.
    Ferreira D; Verhagen C; Hernández-Cabrera JA; Cavallin L; Guo CJ; Ekman U; Muehlboeck JS; Simmons A; Barroso J; Wahlund LO; Westman E
    Sci Rep; 2017 Apr; 7():46263. PubMed ID: 28417965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE ε4 in Nondemented Elderly Subjects.
    Liang X; Yin Z; Liu R; Zhao H; Wu S; Lu J; Qing Z; Wei Y; Yang Q; Zhu B; Xu Y; Zhang B
    Neurodegener Dis; 2018; 18(5-6):270-280. PubMed ID: 30673663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
    Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
    Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    Falgàs N; Balasa M; Bargalló N; Borrego-Écija S; Ramos-Campoy O; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Castellví M; Allen IE; Sánchez-Valle R; Lladó A
    J Alzheimers Dis; 2020; 73(4):1575-1583. PubMed ID: 31958089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience.
    Cotta Ramusino M; Perini G; Vaghi G; Dal Fabbro B; Capelli M; Picascia M; Franciotta D; Farina L; Ballante E; Costa A
    Front Aging Neurosci; 2021; 13():595758. PubMed ID: 33746732
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 18. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis.
    Lee K; Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Kim SY; Chung YI; Kim JH
    Psychogeriatrics; 2019 Mar; 19(2):105-110. PubMed ID: 30430708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.